—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Travere Therapeutics Inc（TVTX）— 同类公司组

数据截至2026-10-07 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。

Travere Therapeutics Inc的Closelook综合评分为43/100，在同类公司组内排名第7位（共7家）——组内评分最高的是BB Biotech AG（74/100）。

名称综合动量质量估值信号距52周高点
TVTX Travere Therapeutics Inc43652811info22.2%
BION.SW BB Biotech AG74639681info12.3%
ONC BeiGene, Ltd.64816532ok5.5%
PTGX Protagonist Therapeutics Inc60776212info12.4%
REGN Regeneron Pharmaceuticals Inc60607252watch14%
CAI Caris Life Sciences, Inc. Common Stock59796226ok19.5%
CORT Corcept Therapeutics Incorporated57965024ok5.4%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-07

Quick answers

Travere Therapeutics Inc在Closelook覆盖范围内的同类公司有哪些？

分组首先基于共同的Closelook指数成分，其次基于行业：BB Biotech AG (BION.SW)、BeiGene, Ltd. (ONC)、Protagonist Therapeutics Inc (PTGX)、Regeneron Pharmaceuticals Inc (REGN)、Caris Life Sciences, Inc. Common Stock (CAI)、Corcept Therapeutics Incorporated (CORT)。

TVTX相对同类公司的评分如何？

Travere Therapeutics Inc的综合评分为43/100，组内排名第7位（共7家），截至2026-10-07；组内最高综合评分为BB Biotech AG（74/100）。Closelook评分为研究日记读数，不构成评级或投资建议。

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.